BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,873 | +12.3% | 85 | 0.0% | 0.00% | – |
| Q1 2023 | $3,448 | -20.4% | 85 | 0.0% | 0.00% | – |
| Q4 2022 | $4,332 | -13.4% | 85 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | 0.0% | 85 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -28.6% | 85 | 0.0% | 0.00% | – |
| Q1 2022 | $7,000 | 0.0% | 85 | 0.0% | 0.00% | – |
| Q4 2021 | $7,000 | 0.0% | 85 | 0.0% | 0.00% | – |
| Q3 2021 | $7,000 | 0.0% | 85 | 0.0% | 0.00% | – |
| Q2 2021 | $7,000 | 0.0% | 85 | 0.0% | 0.00% | – |
| Q1 2021 | $7,000 | 0.0% | 85 | 0.0% | 0.00% | – |
| Q4 2020 | $7,000 | -56.2% | 85 | -58.5% | 0.00% | -100.0% |
| Q3 2020 | $16,000 | -11.1% | 205 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $18,000 | +157.1% | 205 | +141.2% | 0.00% | 0.0% |
| Q1 2020 | $7,000 | 0.0% | 85 | 0.0% | 0.00% | – |
| Q4 2019 | $7,000 | 0.0% | 85 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $7,000 | 0.0% | 85 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $7,000 | -53.3% | 85 | -54.1% | 0.00% | 0.0% |
| Q1 2019 | $15,000 | +25.0% | 185 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $12,000 | -14.3% | 185 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $14,000 | 0.0% | 185 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $14,000 | +16.7% | 185 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $12,000 | 0.0% | 185 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $12,000 | +140.0% | 185 | +117.6% | 0.00% | – |
| Q3 2017 | $5,000 | 0.0% | 85 | 0.0% | 0.00% | – |
| Q2 2017 | $5,000 | +25.0% | 85 | 0.0% | 0.00% | – |
| Q1 2017 | $4,000 | 0.0% | 85 | 0.0% | 0.00% | – |
| Q4 2016 | $4,000 | 0.0% | 85 | 0.0% | 0.00% | – |
| Q3 2016 | $4,000 | -81.0% | 85 | -83.3% | 0.00% | -100.0% |
| Q1 2016 | $21,000 | +10.5% | 510 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $19,000 | +11.8% | 510 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $17,000 | -81.5% | 510 | -61.4% | 0.00% | -83.3% |
| Q2 2015 | $92,000 | -90.8% | 1,320 | -90.9% | 0.01% | -90.7% |
| Q1 2015 | $999,000 | -68.0% | 14,585 | -65.8% | 0.13% | -68.7% |
| Q4 2014 | $3,124,000 | +44.4% | 42,630 | +41.4% | 0.41% | +30.0% |
| Q3 2014 | $2,163,000 | +7.7% | 30,140 | +8.5% | 0.32% | +7.1% |
| Q2 2014 | $2,009,000 | +3.7% | 27,785 | +5.5% | 0.30% | +9.6% |
| Q1 2014 | $1,937,000 | +36.7% | 26,325 | +29.2% | 0.27% | +35.7% |
| Q4 2013 | $1,417,000 | +4.0% | 20,375 | -1.8% | 0.20% | -8.7% |
| Q3 2013 | $1,363,000 | +21.0% | 20,750 | +27.7% | 0.22% | +12.4% |
| Q2 2013 | $1,126,000 | – | 16,250 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |